SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-24-040937
Filing Date
2024-05-08
Accepted
2024-05-08 17:13:05
Documents
2
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea0205486-13gintra_tffpharma.htm SC 13G 102562
2 JOINT FILING AGREEMENT ea020548601ex99-1_tffpharma.htm EX-99.1 3238
  Complete submission text file 0001213900-24-040937.txt   107380
Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

IRS No.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91311 | Film No.: 24927470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)